Multiple Sclerosis (MS) experimental treatment

Complicated Medical Procedures: Multiple=Mrs. L. Z. is a 28 years old professional sportswoman form Canada, affected with Multiple Sclerosis. Her doctors referred her, via iMER, to Prof. Dimitrios Karussis, a world famous MS specialist, that is developing a new experimental treatment for this syndrome. Mrs. Louise Z. was accepted to be one of the test cases for Prof. Karussis experimental treatment.

Ms. L. Z. arrived on November. 2007 to begin her treatment and bone marrow cells aspiration. The stem cells that were taken from the marrow were cultivated in vitro and then by April 2008, they were transplanted back to her.

Ms. L.Z. wrote to us:

April 24. 2008
Mr. IIan Tamir

Chief Operating Officer I Chief Executive Officer IMER – Hadassah Medical Center

Mr. IIan Tamir.

I would like to express my sincere gratitude and appreciation for the wonderful experience I had dealing with your company since November of last year.

………………………………………………..

Please know that you staff goes above and beyond in making patients feel welcome in their country. It has been proven time and time again. They made every effort to ensure that my stay was as enjoyable and easy as possible.

………………………………………………..

Again I can not express what a wonderful experience I have had over the last 6 months. I have communicated my experiences to others and have recommended IMER to those who have medical issues. You should be very proud of your staff and the services you provide!

Sincerely,

L. Z.

For more information click here >>

Patients’ Stories

Mr. I. B., was diagnosed with Multiple Sclerosis, manifesting symptoms of Progressive Refractory Disease, some 5 years ago. His condition deteriorated rapidly and 2 years ago he was bound to a wheelchair, practically incapable of moving, preparing for the worst. The MS disease is related to the autoimmune system. Therefore, the Bone Marrow Transplant (BMT) unit of the Hadassah Medical center took the case and decided to use the BMT procedure to treat this patient. Usually, in the treatment of this affection, healthy marrow cells
Read More >>